KORRO BIO INC
KRRONASDAQ🏆 #3596 by market capEarnings Nov 18US Equity
——
Quote unavailableTrack KRRO
Get earnings, price moves & breaking news on Telegram
24h—
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$196M
Small Cap
📈Revenue Growth (YoY)
181.5%
High Growth
📊Gross Margin
72.8%
High
💵FCF Margin
-2865.9%
Thin
⚖️P/S Ratio
82.2x
Expensive
Otter Score
60
Fair
No chart data available for KRRO.
Trading Snapshot
- Day Range
- —
- 52-Week Range
- $5.20 – $42.70
- Volume (shares)
- —
- Avg Volume (shares)
- —
- Shares Outstanding
- 14.7M
- Next Earnings
- 2026-11-18
Fundamentals Snapshot
- Annual Revenue
- $6M
- Last Q Revenue
- —
- P/E Ratio
- -1.3
- P/S Ratio
- 82.2x
- EPS (TTM)
- $-6.05
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +5.3%
KORRO BIO INC
KRROFinancial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$6M▲ +181.5% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
33.0%▼ −67.0% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$87M▼ −5.0% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$79M▲ +1.4% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
9.4M▲ +5.3% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
−$22M▼ −$33M YoY
StockOtter · stockotter.spaceAbout KORRO BIO INC
Korro Bio, Inc., a biopharmaceutical firm based in Cambridge, Massachusetts, is dedicated to exploring, advancing, and bringing to market genetic therapeutics. These treatments are formulated through RNA editing technology, aiming to address a wide array of medical conditions, encompassing both uncommon and widespread diseases.
🦦
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Fair
60/100
Analyst data unavailable.
Latest News & Updates
News unavailable.